By
Trending Posts
Unlearn AI’s Breakthroughs in AI-Driven Clinical Development: 2024…
San Francisco – December 12, 2024 Unlearn AI has emerged as a leader in AI-powered clinical trial innovation,…
How Unlearn AI Is Increasing the Efficiency of…
December 11, 2024 Enhanced TwinRCT™ 3.0 Unlearn® has introduced an upgraded version of its AI-driven TwinRCT™ solution—TwinRCT 3.0,…
Relation Therapeutics, NVIDIA-Backed AI-Biotech, and GSK Announce Strategic…
London, UK – December 10, 2024 Relation, a leader in computational and experimental drug discovery, has announced two…
Recursion Reports Promising Interim Data for AI-Designed CDK7…
Salt Lake City – December 9, 2024 Recursion (Nasdaq: RXRX), a leader in AI-powered drug discovery, has released…
Recursion Doses First Patient in Phase 1/2 Trial…
Recursion (NASDAQ: RXRX), a cutting-edge clinical-stage TechBio company, has announced the successful dosing of the first patient in…
AI Drug Discovery Leaders Recursion and Exscientia Merge…
Recursion and Exscientia, two trailblazers in AI-driven drug discovery, have officially merged to form a technology-powered platform aimed…
NVIDIA Expands AI-Driven Drug Discovery with BioNeMo Framework
November 18, 2024 NVIDIA has launched a major initiative to scale AI-powered drug discovery through the open-source BioNeMo…
ImmunAI and Teva Partner to Enhance Clinical Trials…
New York, NY – Nov 14, 2024 Strategic Collaboration Aims to Improve Drug Development Efficiency and Patient Outcomes:ImmunAI,…
Medable and Google Cloud Partner to Advance AI-Powered…
PALO ALTO, Calif. – October 30, 2024 Strategic Collaboration to Accelerate Clinical Research Medable Inc., a leader in…
Trending Posts
Latest Stories
Can Parallel Bio’s $21M Bet on Immune Organoids Cut Drug Failure Rates from 95% to 5%?
Key Highlights Organoid-AI Platform Aims to Transform Preclinical Drug DiscoveryParallel Bio’s proprietary platform replicates the…
Can BullFrog AI and Sygnature Discovery’s $30M Alliance Reshape How Global Biopharma Uses AI in Drug Discovery?
Key Highlights BullFrog AI Secures Global CRO Partner to Scale AI PlatformBullFrog AI has entered…
Can Receptor.AI’s Integration of REAXENSE™ Platform Redefine Full-Stack Drug Discovery?
Key Insights: Advanced Chemistry at ScaleReceptor.AI has incorporated the REAXENSE™ platform, developed by Canada-based Reaxense…
How Are NUS and UC San Diego Using AI to Unlock Sex-Specific Drug Combos for Aortic Valve Disease?
Key Highlights: AI-Powered Personalization: Unlocking Sex-Specific Drug EfficacyThe collaboration between the National University of Singapore’s…
Gallery
